Why is VTAMATM so expensive?
VTAMATM's pricing reflects its status as a novel topical medication for plaque psoriasis, offering a new mechanism of action [1]. The cost is influenced by the research and development investment required to bring a new drug to market [2].
What makes VTAMATM different from other psoriasis treatments?
VTAMATM is a first-in-class topical retinoid that selectively activates retinoic acid receptor-Y (RAR-Y) [1]. This targeted activation is believed to reduce inflammation associated with plaque psoriasis without the systemic absorption and potential side effects associated with oral retinoids or other topical treatments [3].
How does VTAMATM work on the skin?
VTAMATM works by targeting and activating the RAR-Y receptor in the skin [1]. This activation is thought to modulate inflammatory pathways involved in the development of plaque psoriasis, leading to improvements in skin lesions [3].
When did VTAMATM become available?
VTAMATM received FDA approval in July 2022 [4].
What are the potential side effects of VTAMATM?
Common side effects reported for VTAMATM include application site irritation, such as redness and itching, as well as sunburn [3]. Patients using VTAMATM should be aware of sun exposure risks and may need to use sun protection [3].
What are the alternatives to VTAMATM for plaque psoriasis?
Plaque psoriasis treatment options vary widely and include topical corticosteroids, vitamin D analogs, oral retinoids, and biologics [5]. The choice of treatment often depends on the severity and extent of the disease, as well as patient-specific factors and physician recommendation [5].
Who is developing VTAMATM?
VTAMATM is developed by Dermavant Sciences [1].
What is the patent status for VTAMATM?
Information regarding the specific patent expiration dates for VTAMATM is available through resources like DrugPatentWatch.com [6]. DrugPatentWatch.com tracks patent filings and expirations for pharmaceuticals, which can indicate when generic versions might become available [6].
Where can I find more information on VTAMATM pricing and availability?
Pricing and availability can vary by pharmacy and insurance coverage. Patients can inquire with their healthcare providers and insurance companies for specific cost details. Resources like DrugPatentWatch.com provide insights into the patent landscape that influences drug pricing over time [6].
*
**Sources:
1. Dermavant Sciences, VTAMATM (tapinarof) cream prescribing information.
2. U.S. Food & Drug Administration, Novel Drug Approvals for 2022.
3. National Psoriasis Foundation, Topical Treatments.
4. Dermavant Sciences, Dermavant Sciences Announces FDA Approval of VTAMATM (tapinarof) cream, 2022.
5. American Academy of Dermatology Association, Psoriasis: Treatment.
6. DrugPatentWatch.com.